Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ovid Therapeutics (OVID) Net Cash Flow (2020 - 2025)

Ovid Therapeutics' Net Cash Flow history spans 6 years, with the latest figure at -$7.3 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 164.31% year-over-year to -$7.3 million; the TTM value through Dec 2025 reached -$12.9 million, down 1649.59%, while the annual FY2025 figure was -$12.9 million, 1649.59% down from the prior year.
  • Net Cash Flow reached -$7.3 million in Q4 2025 per OVID's latest filing, up from -$7.8 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $161.0 million in Q1 2021 to a low of -$93.9 million in Q2 2022.
  • Average Net Cash Flow over 5 years is -$2.8 million, with a median of -$9.1 million recorded in 2021.
  • Peak YoY movement for Net Cash Flow: soared 1205.87% in 2021, then plummeted 349.4% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at -$12.1 million in 2021, then dropped by 11.1% to -$13.4 million in 2022, then crashed by 127.01% to -$30.4 million in 2023, then skyrocketed by 137.13% to $11.3 million in 2024, then tumbled by 164.31% to -$7.3 million in 2025.
  • Per Business Quant, the three most recent readings for OVID's Net Cash Flow are -$7.3 million (Q4 2025), -$7.8 million (Q3 2025), and $7.3 million (Q2 2025).